Shawn Iadonato

CEO, Kineta

Shawn Iadonato, Ph.D., serves as Kineta's chief executive officer. He is a co-founder of Kineta and previously served as chief scientific officer. Under his leadership as CSO, the Kineta pipeline expanded to include the AviiD Screening Platform and five novel drug and vaccine programs with a focus on autoimmune diseases, antivirals, and chronic pain.

Prior to founding Kineta, Shawn co-founded and served as CSO of Illumigen Biosciences Inc. At Illumigen Biosciences, he pioneered its patented drug discovery platform, which relied upon recruitment and screening of healthy populations and elucidation of their shared "wellness" genes. Shawn also led the successful discovery and preclinical development of Illumigen's anti-hepatitis C drug, which ultimately led to the sale of the company in December 2007 to Cubist Pharmaceuticals (now part of Merck & Co.).

Before Illumigen, Shawn managed the Human Genome Center at the University of Washington. He is co-inventor on more than 35 US patents or patent applications. He is principal investigator or co-investigator on numerous ongoing government grants and contracts.

Shawn received a Ph.D. in Genetics from the University of Washington and is a graduate of the University of Pennsylvania.


Share this: Share on Facebook Tweet about this on Twitter Share on Google+ Share on LinkedIn Email this to someone

News for: Shawn Iadonato

Speaker at FiRe 2016

News Headlines
Kineta Invited to Participate at Solebury Trout's 9th Annual CEO Roundtable C...
Posted on 12 Aug 2019 at 5:53am

Kineta Raises $1.8M in Funding
Posted on 6 Aug 2019 at 1:34pm

Kineta Secures $1.8 Million Funding Boost from Wellcome Trust on Positive Pha...
Posted on 6 Aug 2019 at 1:54am

Local drug makers race to develop non-opioid pain medication
Posted on 12 Jun 2019 at 11:27am

Kineta Secures NIAID Grant Worth Up to $5.8M to Evaluate LHF-535 in Arenaviruses
Posted on 14 Jul 2019 at 5:00pm

Kineta, Playing for Bunt Singles, Builds a Biotech Company Without VC Bucks
Posted on 5 Jun 2019 at 5:00pm

PSBJ Innovator: Shawn Iadonato, Kineta CEO (long version) (Video)
Posted on 22 May 2019 at 12:01pm

Kineta Invited to Participate at Solebury Trout's 9th Annual CEO Roundtable C...
Posted on 11 Aug 2019 at 5:00pm

Kineta Acquires Multiple Sclerosis, Diabetes Drug Candidates to Test Unusual ...
Posted on 7 Jul 2019 at 5:00pm

Kineta Invited to Participate at Solebury Trout's 9th Annual CEO Roundtable C...
Posted on 12 Aug 2019 at 5:54am



News feeds courtesy of:

FiRe 2016 Media


Bleeding-Edge Medicine: Today's Discoveries, Tomorrow's Practice



Share this video: Share on Facebook Tweet about this on Twitter Share on Google+ Share on LinkedIn Email this to someone

To contact Shawn Iadonato, fill out the form below.

iNews Mailroom (All fields required)
To:
From:
Your Email:
Subject:

Message: